Corsano Health

About:

MedTech Patient Monitoring

Website: https://corsano.com

Description:

Corsano Health, based in The Netherlands with offices in Switzerland, is a leading wearable MedTech company developing, producing and marketing medical smart monitoring devices designed to measure vital parameters 24/7 using wireless, non-invasive, and medical-grade technology. Corsano Health B.V. is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards. The Corsano brand name is derived from in corpore sano (in a healthy body). Corsano’s CardioWatch 287 is a cardiac arrhythmia screening system that provides a simple and effective method for continuous monitoring of up to 19 vital parameter measurements (i.e., Heart Rate, RR Intervals, Respiration Rate, SpO2, Sleep, Activity, ECG, BIOZ, Core Body Temperature, Cuffless Blood Pressure).

Total Funding Amount:

15M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

The Hague, Zuid-Holland, The Netherlands

Founded Date:

2019-09-03

Contact Email:

info(AT)corsano.com

Founders:

Peter Stas

Number of Employees:

11-50

Last Funding Date:

2020-04-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai